You are here:
Download documents related to Gavi's strategy: a roadmap designed to
help us respond to changes in the vaccine landscape and set five-year
milestones en route to fulfilling our mission.
27 March 2017
Gavi 2016-2020 Strategy Indicator Baselines and Targets
This document summarises the 2015 baselines and 2020 targets for each of the Board-approved indicators tracking the Vaccine Alliance’s progress against the 2016-2020 Strategy. Future updates will include annual indicator values and yearly targets as needed to show progress.
Gavi 2016-2020 Strategy Indicator Definitions
This document provides detailed definitions for each of the Board-approved indicators tracking the Vaccine Alliance’s progress against the 2016-2020 Strategy.
14 February 2014
Overview of the public consultation on supply chain strategy
In July 2013 the GAVI Alliance held a public consultation to seek feedback from global and country stakeholders on a list of supply chain challenges and an emerging strategy framework to address those challenges. The consultation helped us map out and prioritise the activities needed to help strengthen immunization supply chain practices.
28 November 2013
Final VIS analysis 2013: Rabies
Rabies Vaccine Investment Strategy November 2013 - Background document.
Summary consultations phase II
VIS Phase II Consultation 2013.
Final VIS analysis 2013: Malaria
Malaria Vaccine investment strategy November 2013 - Background document.
Final VIS analysis 2013: Maternal Influenza
Influenza Vaccine investment strategy November 2013 - Background document.
Summary consultations phase II [French]
Final VIS analysis 2013: Yellow Fever
Yellow fever Vaccine investment strategy November 2013 - Background document.
Final VIS analysis 2013: Cholera
Cholera Vaccine investment strategy November 2013 - Background document.
22 November 2013
VIS Independent Expert Committee
Independent Expert Committee for the Vaccine Investment Strategy.
24 October 2013
Definition of performance indicators for GAVI strategy 2011-2015
This GAVI Alliance Board paper, approved at the December 2010 Board meeting in Rwanda, lists goal-level indicators to monitor progress against GAVI's 2011-15 strategy.
11 October 2013
VIS prioritisation methodology
VIS phase I: vaccine and disease parameters assessed 1 Phase I Indicator Health impact Impact on child mortality U5 future deaths averted, 2015 – 2030 U5 future deaths averted per 100,000 vaccinated population Impact on overall mortality Total future deaths averted, 2015 – 2030 Total future deaths averted per 100,000 v
10 July 2013
Vaccine Investment Strategy 2013 Phase I - Vaccine Scorecards
VIS 2013 PHASE I 1. Procurement cost includes vaccine, syringe, safety box, and freight 2. Scoring based on cost per future death averted Cholera Phase I Scorecard Modelled scenario: periodic campaigns every 3 years targeting high risk 1-<15 year olds Category VIS Criteria Phase I Indicator Phase I Evaluation Health im
07 June 2013
GAVI Business Plan 2013-2014: deliverables and activities
Strategic objective PO Programme objective Interim deliverable (2013) Interim deliverable (2014) Programme deliverables (2015) 2.3. Strengthen civil society engagement in the health sector 2.3.1 Promote active engagement of Civil Society Organisations (CSOs) At least 50% of countries, supported by partners, have active
29 May 2013
GAVI Business Plan 2013-2014: Background narrative
The GAVI Alliance Business Plan aims to support GAVI’s mission to save children’s lives and protect people’s health by improving access to immunisation in poor countries.
21 December 2011
2010 Work Plan Report
The 2010 Work Plan Report highlights the 2010 progress under each output of the 2007-2010 work plan.
01 February 2011
Kenya : pneumonia and pneumococcal disease
Childhood pneumonia is a major public health issue in Kenya; it is the second leading cause of death among children under five. Thanks to the AMC, two vaccines (PCV10 and PCV13) against pneumococcal disease have been approved so far for introduction in GAVI-eligible countries.
01 December 2010
GAVI Alliance monitoring and evaluation framework and strategy 2011-2015
The Monitoring and Evaluation Framework and Strategy is designed to contribute to meeting the GAVI Alliance’s diverse information needs, including those related to internal business processes, support to countries and overall effectiveness, efficiency and impact.
GAVI Alliance Strategy and Business Plan 2011-2015
This GAVI Alliance Business Plan 2011-2015 describes the actions to be undertaken to achieve the 2011-2015 Strategy, while also laying out the context and challenges for the coming years.
27 March 2009
Oxford Declaration - cervical cancer in Africa
The Oxford Declaration is a call to action on the prevention of cervical cancer in Africa; agreed upon by members on 27 March 2009.
05 January 2009
Vaccine Investment Strategy – GAVI’s strategic approach
GAVI s strategic approach GAVI is developing a comprehensive vaccine investment strategy in 2008 to determine which vaccines it will offer to countries in the future, ensuring the best use of resources and maximum immunisation impact.
29 October 2008
Vaccine Investment Strategy - Rabies analysis
Applied Strategies Consulting Project - Vaccine Investment Strategy - Rabies analysis
Vaccine Investment Strategy - Japanese Encephalitis Analysis
Applied Strategies Consulting Project - Vaccine Investment Strategy - Japanese Encephalitis Analysis
Vaccine investment strategy - Vaccine Portfolio Analysis
GAVI Vaccine Investment Strategy -- Project Vaccine Portfolio Analysis by Applied Strategies.
Vaccine investment strategy - Executive summary
27 October 2008
Vaccine Investment Strategy - Typhoid analysis
Applied Strategies Consulting Project - Vaccine Investment Strategy - Typhoid analysis
Vaccine Investment Strategy - HPV analysis documentation
Applied Strategies Consultancy Projecton GAVI's Vaccine Investment Strategy for the human papillomavirus.
Cholera analysis documentation
Cholera analysis presentation from Applied Strategies Consulting.
29 September 2008
Vaccine Investment Strategy - Working Group Review, Washington DC 29-30 September 2008
The working group met in Washington DC to review the methodology and outcomes of the analyses performed as part of the Vaccine Investment Strategy project and to provide guidance and feedback to the Secretariat on a recommendation for the GAVI Board.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here